Cited by 10Bariatric Surgery and OutcomesPharmacology and Obesity TreatmentObesity, Physical Activity, Diet

Weight management treatment modalities in patients with overweight or obesity: A retrospective cohort study of administrative claims data

Open access
Kan, Hong, Swindle, Jason P., Bae, Jay, Dunn, Julia P., Buysman, Erin K., Gronroos, Noelle N., Bengtson, Lindsay, Chinthammit, Chanadda +2 more·2023·Obesity Pillars

Abstract

Background: The purpose of this study was to describe demographic and clinical characteristics among patients who have medical encounters for weight management treatments and to investigate the association of those characteristics with treatment modality. Methods: This was a retrospective database study using medical claims, pharmacy claims, and enrollment information from commercial and Medicare Advantage with Part D members in the Optum Research Database from 01/01/2011-2/29/2020. Adult patients with a claim for a weight management treatment from 01/01/2012-2/28/2019 were categorized into cohorts according to the highest intensity intervention received. To examine the association between patient characteristics and treatment modality received, a multinomial logit model was performed. Results: Cohorts by increasing intensity included lifestyle intervention (LSI, n = 67,679), weight reduction pharmacotherapy (WRRx) with an anti-obesity medication (AOM, n = 6,905), weight reduction procedure (WRP, n = 1,172), and weight reduction surgery (WRS, n = 18,036). Approximately 32.1% and 16.6% of patients who received WRS or WRP had an LSI during the 12-month baseline, and only 0.6% and 0.4% had treatment with long-term AOMs. In a multinomial logit model, patients with type 2 diabetes (not including WRRx cohort), respiratory disorders, cardiovascular risk factors, pain disorders, and mental health conditions had increased odds of treatment with higher intensity intervention versus LSI. Patients who were male, received an intervention more recently (2016-2019), or had a Charlson comorbidity score of 1 (compared to 0) had decreased odds of treatment with higher intensity interventions. Conclusion: In this study, age, sex, body mass index, obesity-related complications, and Charlson comorbidity score appeared to influence the type of weight management treatment modality received. This study improves understanding of weight management treatment utilization and identifies gaps and opportunities to improve obesity care with the appropriate use of different treatment modalities.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.obpill.2023.100072

Cites

60 of 60 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Research works printed but not linked: 1

  1. [61]Perreault L. Kramer E.S. Smith P.C. Schmidt D. Argyropoulos A closer look at weight loss interventions in primary care: a systematic review and meta-analysis Preprint available at: www.medrxiv.org/content/10.1101/2022.08.03.22278290v1 2022 PMC10701393 38076252 · DOI

Cited by

Sorted by citations

Authors
Kan, H., Swindle, J. P., Bae, J., Dunn, J. P., Buysman, E. K., Gronroos, N. N., Bengtson, L., Chinthammit, C., Ford, J., & Ahmad, N.
Affiliations
  • Eli Lilly (United States) (US)
  • Optum (United States) (US)
Corresponding author
Gronroos, Noelle N.
Venue
Obesity Pillars
Publisher
Elsevier BV
Published
2023-09
Volume
7
Pages
100072
ISSN
2667-3681 (ISSN-L)
OpenAlex
W4377690858
Cited by
10
References
60
Citations by year
2026: 5 · 2025: 5
FWCI
2.68
Type
journal article
Language
en
Open access
Locations
  • Obesity Pillars (publishedVersion, cc-by-nc-nd)
  • PubMed Central (publishedVersion, cc-by-nc-nd)
  • PubMed (publishedVersion)
Funders
Eli Lilly and Company
Topics
  • Health Sciences › Medicine › Surgery › Bariatric Surgery and Outcomes
  • Health Sciences › Medicine › Pharmacology › Pharmacology and Obesity Treatment
  • Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Obesity, Physical Activity, Diet
Keywords
obesity, overweight, weight reduction surgery, anti-obesity drugs, lifestyle intervention, treatment intensity, patient characteristics, type 2 diabetes, comorbidities

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review